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3 
Modes of Sensory Processing 
 
 
The constant  exchange of information between animals and the 
environment has played a fundamental role in the design, evolution 
and optimization of the sensory system. Sophisticated neuronal 
mechanisms have been developed in order to detect and 
discriminate among various classes of environmental stimuli acting 
on the body surface and internal organs. . Primary sensory neurons 
convey information from the periphery to the spinal cord or the 
brainstem. Their soma is located in the Dorsal Root Ganglia (DRG), 
for sensory information generated in the body, and trigeminal 
ganglia for sensory information originated in the head. This 
particular type of neurons are defined pseudounipolar because a 
single axon arise from the cell body and then bifurcates, sending 
one process toward the spinal cord through the dorsal root, while the 
other progress peripherally reaching skin, muscles and visceral 
organs . Each type of sensory stimulus thermal, mechanical, and 
chemical depolarise peripheral sensory receptors which turn this 
stimuli in to train of electric impulses. This neuronal activity is than 
conveyed from the periphery to the central nervous system, where it 
is interpreted by the brain as sensations corresponding to the type of 
stimulus applied . These receptors can be classified on the basis of 
the adequate stimulus which can elicit their activity, hence they are 
divided as chemoreceptors, thermoreceptors, mechanoreceptors 
and photoreceptors . Another classification take in to consideration 
their location in the body recognising two main type of receptors: 
exteroreceptors, which are located near the body surface and detect 
changes in the external environment that affect the organism, and 
interoreceptors located within the viscera which detect changes in 
the internal environment. Exteroreceptors include primary sensory 
neurons for touch, temperature, pressure and noxious stimuli 
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which belongs to the General Somatic Afferent (GSA) System, 
neurons for light and sound belonging to the Special Somatic 
Afferent (SSA) System and neurons for General and Special 
Proprioception. Interoreceptors comprehend General Visceral 
Afferent (GVA) neurons responsible for detection of body 
temperature, blood pressure, gas concentration, pressure and 
movement of body viscera and the Special Visceral Afferent neurons 
responsible for chemical stimuli such as taste and smell . 
Nociceptors are a peculiar group of receptors giving the fact that 
they are not specific for the type of stimulus which is necessary to 
elicit their activity, hence mechanical, chemicals or thermal stimuli 
are able to generate electric impulses on this neurons. The 
specificity of this receptors is rather due to the intensity of the 
applied stimulus, thus they start firing when the degree of the 
stimulus is potentially destructive for the tissue, that is when the 
stimulus became noxious and the organism start experiencing pain . 
 
 
Nociception and Neuropathic Pain 
 
Pain has been defined by the International Association for the Study of 
Pain as “an unpleasant sensory and emotional experience associated 
with actual or potential tissue damage”. Pain is one of the most 
important function which help us to preserve the body and teach us to 
avoid potentially damaging situations, protect wounds while healing 
and prevent the recurrence of painful states in the future. Furthermore 
the experience of pain is not only physical but also emotional, thus it 
can heavily influence people and animals behaviours, especially when 
the acute painful state turns in to a chronic condition. . 
The sensation of pain in the past was considered only related to 
events that could trigger the activity of peripheral receptors which 
subsequently transfer the painful information through the spinal cord 
up to the brain. In this simplistic view of the nociceptive pathway 
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central mechanisms were considered merely transmitters of impulses 
generated in the periphery . According to this theory, patients that 
reported painful experiences in the absence of evident peripheral 
noxious stimulus they were assigned to psychiatric care as neurotics, 
hypochondriacs or hallucinators . Nowadays it is well known that 
central mechanisms are of great importance in the experience of pain 
which has been initiated by peripheral stimulation of nociceptors . 
Recognising the importance of the somatosensory transmission 
mechanisms the International Association for the Study of Pain define 
also “pain initiated or caused by a primary lesion or dysfunction of the 
nervous system that, under normal conditions transmit noxious 
information” as Neuropathic Pain (NP). This kind of pain is a 
pathologic condition which affect a sensory pathway and it does not 
bring any benefit for the organism for there is no apparent reason to 
trigger the nociceptive function. .  
Neuropathic pain can develop following primary lesions or disfunctions 
in any part of the nervous system, from the peripheral receptor to the 
brain, thus degenerative spinal cord diseases, diabetes, herpes zoster 
infection, mechanical injuries of the nerves and spinal cord, AIDS, 
painful surgeries such as thoracotomies and mastectomies, 
amputation and stroke are just some of the condition that can cause 
this pathological state . Regardless of the initial primary site of pain, 
the condition evolve through time with a subsequent spread of pain 
generating mechanisms due to biochemical changes within the 
nervous system, therefore Neuropathic Pain should be considered a 
progressive nervous system disease . In addiction at the unpleasant 
feelings of protracted pain, there are many psychological and social 
aspects because this condition affect also a person’s quality of life, in 
the meaning of interferences in sleep, work, recreation and emotional 
well-being .  
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Pathophysiology of Neuropathic Pain 
 
So far, researches in vivo and in vitro indicate that a lesion of the 
afferent pathway is necessary for development of neuropathic pain, 
and it is now known that there is not a single but rather several 
mechanisms involved . Many of these mechanisms are independent 
on the cause of the primary disease, thus the same mechanisms can 
be found in several conditions, and different mechanisms can produce 
the same painful pattern. This highlight the importance of the 
understanding of the underlying pain mechanism for the individual 
patient in order to establish the correct management, because a 
mechanism-based treatment approach can lead to efficient analgesia . 
Physiologically pain is elicited through the application of an appropriate 
stimulus which, can be either mechanical, chemical or thermic in every 
part of the body. The cell bodies of peripheral sensory nerves are 
located in the dorsal root ganglia of the dorsal root of the spinal nerves 
and the trigeminal ganglia for cranial nerves. Under normal conditions 
A delta fibers and C fibers are those responsible for the transmission 
of noxious stimuli. The A delta fibers are rapidly conducting and thinly 
myelinated, they have small receptive fields and are activated by 
noxious thermal or mechanical input. Their transmission is rapid and 
therefore are responsible for the initial sensation of pain (first pain), 
which is sharp, pierce, localized and transient. This protective 
mechanism warns us immediately to withdraw a body part from a 
potential major damage. C fibers are slowly conducting and 
unmyelinated, they have larger receptive fields and are activated by 
thermal, mechanical or chemical stimuli of higher intensity compared 
to A delta fibers. They are responsible for the second pain which is 
burning and throbbing . 
Once the information has reached the dorsal root of the spinal nerve it 
enters into the dorsal horn of the spinal cord, at the level of laminae I 
and II. The sensory input is than transferred via the ascending 
nociceptive pathway (spinothalamic tract) through the spinal cord and 
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brainstem up to the thalamus. From here the information reaches the 
cortex, where pain is perceived and a behavioural response, such as 
withdrawal from the noxious stimulation, is made. Furthermore 
projections to the hypothalamus initiate a neuroendocrine and 
autonomic response, while descending modulatory pathways, or 
inhibitory systems, function to reduce the degree of pain perceived, 
acting as a “gate” to further noxious inputs and activating endogenous 
analgesic systems . 
 
 
 
 
Fig 1. Most nociceptors are unmyelinated with small diameter axons (C-fibers, red). 
Their peripheral afferent innervates the skin (dermis and/or epidermis) and central 
process projects to superficial laminae I and II of the dorsal horn  
 
 
 
In the absence of tissue injury the afferent discharges evoked by a 
painful stimulus terminate with cessation of the stimulation. Whether 
this stimulation is accompanied by an injury to a tissue, especially 
nervous tissue, an inflammatory states occurs and C-fibers produce an 
ongoing afferent discharge that persists after the original insult has 
ceased. The release of chemical mediators such as the Arachidonic 
Acid (AA) cascade and subsequent eicosanoid production facilitate 
neurons firing, through a recruitment and activation of more silent 
nociceptors which in turn release an increased amount of substance-P 
(S-P) a pronociceptive peptide neurotransmitter. Such 
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modifications of the peripheral afferent sensory pathway results in an 
increased input towards the spinal cord, which results in an increased 
pain response for a given stimulus that under normal conditions would 
have elicited less pain. This phenomenon is called Peripheral 
Sensitization  
 
 
 
 
Fig. 2. A-fiber nociceptors are myelinated and usually have higher conduction 
velocities respect to C-fibers . A-fiber nociceptors project to superficial laminae I 
and V . 
 
 
 
At the level of the spinal cord the increased amount of 
neurotransmitters act on a particular type of neurons called 
Widedynamic Range (WDR) neurons which tend to respond more 
vigorously to noxious stimulation, and are involved in the expression of 
spinal facilitation of pain, named also wind-up. The constant activation 
of WDR neurons which release glutamate into the synaptic cleft, lead 
to a major activation of N-methyl-D-aspartate (NMDA) receptors, thus 
reflecting a persistent membrane depolarization and a higher rate of 
firing for this neurons. Moreover glutamate, together with Substance P 
and Brain-derived Neurotrophic Factor (BDNF), participates in the 
activation of intracellular signalling cascade increasing the 
membrane’s sensitivity toward subsequent stimulation. This 
modifications that occurs at the level of the central nervous system are 
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named Central Sensitization, which can last hours, weeks or even 
years after the primary triggering event. . 
 
 
Clinical Presentation 
 
Clinical signs reported by patients are areas of abnormal sensation or 
hypersensitivity in the affected zone, and classically this symptoms 
have been divided in to positive and negative sings. Paraesthesia, 
such as skin tingling or burning, spontaneous ongoing pain and burst 
of electric schock-like sensations are considered positive symptoms, 
while negative signs comprehend sensory deficit in response to touch, 
temperature or pinprink. . Positive symptoms are due either to 
peripheral or central sensitization. Changes in the peripheral nerves 
include ectopic activity related to injured sensory neurons and 
increased excitability of the adjacent uninjured neurons, while central 
sensitization is related to the loss of inhibitory mechanisms and an 
increased sensitivity of neurons in the spinal cord and higher centers, 
has previously mentioned. On the other hand, negative symptoms are 
due to neuronal cell loss . 
Patients can experience also mechanical or thermal hypersensitivity, 
and regarding hypersensitivity two distinct type are described: 
allodynia and hyperalgesia. Allodynia is defined as pain in response 
to a nociceptive stimulus, thus even gentle mechanical stimuli such as 
a slight bending of hairs, which under normal conditions wouldn’t 
cause pain, it is capable of evoke severe discomfort. The term 
Hyperalgesia is used to describe an increased pain sensitivity to a 
nociceptive stimulus. For thermally evoked pain, the terms cold and 
heat hyperalgesia have been widely accepted instead of allodynia 
which refers mainly to mechanical stimulation . 
In human medicine, from the clinical point of view, neuropathic pain is 
a well characterized condition, mainly because patients can verbalize 
and describe what they’re experiencing, what it feels like, which body 
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parts are affected and whether or not the treatments are appropriate in 
relieving pain. Animals can experience Neuropathic Pain as well as 
human beings do, but because veterinary patients cannot tell us 
whether they are painful or not things are more difficult for clinicians 
and owners. Disease conditions that can produce neuropathic pain in 
animals include trauma, surgical procedures, pelvic fractures, limb 
nerve entrapment, amputation, lumbosacral lesions, spinal cord injury, 
intervertebral disc herniation, fibrocartilagineous embolic myelopathy, 
syringomyelia, discospondilytis, polyradiculoneuritis, tumors of the 
central nervous system, inflammatory bowel disease and pancreatitis .  
Clinical manifestations are consistent with a painful condition which 
can start in an acute manner and than evolve in to a chronic state, or 
be more insidious and begin to manifests after weeks or months. 
Behavioral changes are frequently reported. Animals can prefer to hide 
or withdraw them to contacts with the owner or other pets, while some 
other can even became aggressive all of a sudden with dangerous 
consequences for people . When the pain is limited to a particular part 
of the body, such as a limb, the animal can manifest lameness, 
obsessive licking, scratching or even biting of the affected area with 
development of severe self-injuries. 
 
 
Treatment of Neuropathic Pain 
 
The management of Neuropathic pain is challenging because despite 
the efforts to develop more rationale therapeutic approach it still 
remains unpredictable the response to most drugs . Many patients do 
not respond or minimally respond to standard analgesic drugs like non 
steroidal anti-inflammatory drugs (NSAIDs) or opioids. This lack of 
pain relief through medications might be a result of the complexity with 
which neuropathic pain develop and the coexistence of psychological 
and emotional aspects of chronic pain . Furthermore, the variety of 
conditions that can lead to neuropathic pain development decrease the 
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likelihood that a single therapeutic intervention can be effective on 
every patient. In the medical literature there are only a moderate 
number of clinical studies on the efficacy of treatment for neuropathic 
pain in humans, while in veterinary medicine there are not even 
published clinical studies, thus the amount of knowledge in this field is 
rather sparse .  
In 2009 the European Federation of Neurological Societies published 
guidelines for neuropathic pain management and Gabapentin (GBP) 
and Pregabalin (PGB) have resulted as first drugs of choice for this 
condition . Gabapentin is an antiepileptic agent and it was designed at 
first as a GABA analog, but as a matter of fact, it has no effect on the 
GABA systems . Both drugs, GBP and PGB bind to Voltage Gated 
Calcium Channels (VGCC) on central terminals of primary afferent 
nociceptors but the exact mechanism of action is controversial. Acute 
inhibition of calcium channel currents, chronic inhibition of calcium 
channel trafficking and interference with binding to thrombospondin 
are some of the suggested mechanisms . 
Published studies on Gabapentin and Pregabalin in the treatment of 
neuropathic pain in veterinary medicine are related to few reports, and 
the need of further studies and randomized clinical trial is fundamental 
for an evidence based approach to this debilitating condition. Clinical 
observations support the hypothesis that, as well as in rodents models, 
dogs can present analogous receptors for gabapentinoids, given the 
fact that gabapentin can produce pain relief . 
 
 
Voltage Gated Calcium Channel and Neuropathic Pain 
 
Voltage-Gated Calcium Channels (VGCC) are a class of cellular 
membrane receptor, which represent the main gate for Calcium entry 
inside excitable cells, and are thus responsible for firing and 
propagation of action potentials in the nervous system through 
influence over neurotransmitters release and activation of intracellular 
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responses . These class of receptors are heteromeric complexes 
constituted by a pore-forming α1 subunit with a transmembrane 
domain, an alpha 2 subunit linked by disulfide bond to a delta subunit, 
which is anchored to the outer surface of the cellular membrane, a 
cytosolic beta subunit and a transmembrane gamma subunit . The 
alpha 2 delta subunit play a fundamental role in the assembly of the 
VGCC and his highly glycosylated constitution provides the crucial 
element for calcium channel stimulation. A common gene encode for 
both peptide α2δ subunit, and so far four genes have been identified 
with a further subdivision in alpha 2 delta 1, alpha 2 delta 2, alpha 2 
delta 3 and alpha 2 delta 4 subunits respectively. These latter subunits 
are present in different tissues, suggesting that they can play a role in 
tissue-specific functions . The presence of the alpha 2 delta subunit 
has been reported in skeletal muscles, heart, Purkinje cells of the 
cerebellum, habenulae, septal nuclei and dorsal root ganglion neurons 
(DRG) . An up regulation of alpha 2 delta subunit in dorsal root 
ganglion cells has been observed in sperimental animal models of 
spinal nerve injury with consequent development of neuropathic pain, 
thus suggesting a correlation of the expression of this VGCC subunits 
and the development of pathologic pain transmission . 
The alpha 2 delta subunits are target receptors for gabapentinoid 
drugs, such as gabapentin (GBP) and pregabalin (PGB), which are, as 
already sad, currently used as antiepileptic drugs, but also for the 
treatment of neuropathic pain conditions . Many researches in 
sperimental animal models have been conducted over the interaction 
among gabapentinoids and these receptors in normal and pathologic 
conditions, but as before mentioned, the mechanisms of action still 
remain unknown . 
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Fig. 3. Transmembrane topology of Voltage Gated Calcium Channel subunits. 
Modified from . 
 
 
 
Why investigate pain mechanisms in animals? 
 
All vertebrate posses a sensory system that detect and process 
noxious stimuli, hence it is reasonable to assume that conditions which 
can cause pain in humans would evoke a similar experience in 
animals. What can largely differ among different species is the 
behaviour pattern in response to pain, which for certain animals may 
be barely detectable and thus more difficult to recognise, mainly 
because they can not express themselves verbally like humans do . As 
individuals we understand the negative impact of pain on our lives and 
we expect and require to treat it efficiently, while as clinicians we need 
to treat painful animals under our care because we have a moral, 
ethical and medical obligation toward them . The increased attention 
for pain and pain management has lead to the establishment of 
organisation such as the International Academy of Veterinary Pain 
Management, but also to the birth of a special interest group of the 
International Association for the Study of Pain focused on pain in non-
human species . 
Neuropathic pain conditions can be easily encountered in veterinary 
medicine, diseases like laminitis, cauda equina syndrome and 
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lameness in large animals, and intervertebral disc disease, 
syringomyelia and discospondilytis in small animals, are just few 
examples were this painful state develops . Despite the number of 
condition in which neuropathic pain is registered, his treatment still 
represent a challenge for the clinician. In many countries in small 
animal and equine practice, non-steroidal anti-inflammatory drugs 
(NSAIDs) and opioids form the most frequently used means of 
managing postoperative pain . Hence it is not surprising that the 
previous mentioned class of drugs as well as local anaesthetics, alfa 
2-adrenergic agonists and ketamine are all licensed for their specific 
use as analgesics in companion animals . Unfortunately neuropathic 
pain often does not responds or partially responds to these standard 
analgesic approach  thus the veterinary surgeon is forced to use 
unlicensed drugs which as been proven to be effective for similar 
conditions in human medicine, reaching variable degrees of success in 
animals. Scientific investigations aimed at the discovery and at the 
understanding of the multiple mechanisms underling the development, 
establishment and perpetration of neuropathic pain are needed in 
order to create new and more effective therapeutic strategies with a 
target drug based approach. Furthermore companion animals, dogs in 
particular, experience nowadays a lifestyle which is much closer to the 
one of human rather than experimental animal models in laboratories, 
and they can develop disease conditions which are quite similar to 
those of people thus giving them a new role as research subjects. 
Animal pain management for several years has benefited from the use 
of analgesic drugs developed for man, but in the next future a better 
understanding of neuropathic pain mechanisms might lead to 
translation of therapies in the opposite direction . 
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Objectives - Materials and Methods 
 
 
Objectives 
 
The primary sensory transmission between DRG neurons and the 
secondary neurons at the dorsal horn of the spinal cord are 
susceptible of modifications under different circumstances thanks to 
neuronal plasticity, as the alterations in neuropathic pain testify 
during pathological states. In the present literature there is a lack of 
information regarding possible changes in the sensory pathway that 
can develop physiologically, but knowledge of the normal situation is 
the cornerstone of a better understanding of pathological changes. 
To prove if modification in the expression of alpha 2 delta subunits in 
DRG cells can occurs under physiologic circumstances, we 
examined two distinct populations of dogs, neonates and adults 
using an immunohistochemical method.  
 
 
Material selection and general procedures 
 
The present investigation was conducted on tissues harvested from 
animals that where delivered to the pathology unit of the Ludwig–
Maximilians Universität, Munich, Germany, for unrelated diagnostic 
procedures. Admission of animals was accompanied by an owner's 
consent regarding the use of tissues for scientific purposes related 
to animal welfare. Collection of animals was non-selective apart 
from exclusion of dogs that exhibited neurological signs or any 
evidence of spinal disease and also orthopaedic disorder. 
For the purpose of our study, the dogs were divided in to two groups 
based on age: neonates and puppies (less than 8 weeks of age; in 
following text summarised under “neonates”) and adult dogs (more 
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than 3 years of age).  
All dogs underwent a full post-mortem examination including 
investigation of the CNS and peripheral nerves. The spinal cord and 
associated nerve roots, including the dorsal root ganglia, were 
removed in toto after removal of the epaxial and paraxial 
musculature, complete laminectomy and removal of transverse 
processes and crista liliaca, as needed.  
 
After careful inspection of the spinal cord and nerve roots, the DRG 
taken from segmental levels: C4, C7, L4 and L7. The tissues very 
immediately transferred into 10% neutral buffered formalin. After 24 
hours of immersion fixation at room temperature on a shaking plate, 
the DRGs where trimmed transversely with a razor blade into slices 
of about 1 mm diameter each. These slices where post fixed in 
formalin and thereafter underwent an automatic processing including 
an ascending alcohol series and embedding in paraffin wax. Of 
these paraffin blocks, microtome sections were performed with a 
slice thickness of 5 µm, and then mounted on positively charged, 
amino-propyl-ethoxy-silane coated slides.  
For both the histological and immunohistochemical staining 
procedures, the sections underwent a standard dewaxing protocol 
employing xylene treatment followed by a decreasing alcohol series 
and washing in distilled water and phosphate-buffered saline PBS 
(pH 7.4). 
 
 
Histological investigations  
 
Before immunohistochemical investigations were launched, all 
DRGs and the associated spinal cord segments underwent a 
neuropathological examination after staining with Haematoxylin-
Eosin (HE). The investigation focused in particular on histological 
evidence of trauma, infiltrative diseases and degenerative features, 
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as induced by foraminal stenosis. Moreover, DRGs anyhow 
indicated or not specifically excluded peripheral nerve damage with 
retrograde DRG involvement where excluded from the group. The 
examination employed general algorithms for pre-vertebral ganglia 
pathology. All investigations were conducted on a Zeiss Axophot® 
equipped with a digital camera. 
 
 
Immunohistochemistry 
 
Pilot investigations were conducted in order to identify the optimal 
antigen retrieval scheme and primary antibody concentration for the 
planned setting. These procedures include different modes of heat 
pre-treatment and enzymatic digestion. The following text only 
includes the most suitable and reproducible method. 
 
Once dewaxed, the slides were treated for Endogenous peroxidase 
activity blocking using a solution with methanol and hydrogen 
peroxide (100ml of Methanol plus 3 ml of Hydrogen Peroxide 30%) 
for 30 minutes, with a subsequent washing in PBS for 15 minutes. 
Non-immune goat serum at a dilution of 1:200 was added to reduce 
unwanted binding between antibodies and proteins of no interest for 
the investigation, for a 30 minutes period. All these steps were 
conducted at room temperature. 
The primary antibody used for this study was a rabbit polyclonal 
antibody (Calcium channel L type DHPR alpha 2 subunit antibody, 
(ab65266) from Abcam®, Cambridge, UK) produced by 
immunization of rabbit with a purified 1,4-dihydropyridine (DHP) from 
synthetic peptide human Calcium channel L type DHPR alpha 2 
subunit. The sections were incubated with the primary antibody at a 
dilution of 1:200 at 4°C overnight in a humidified chamber, followed 
by a PBS bath for 15 minutes to remove the excess of antibodies. 
An avidin-biotin complex method (Vecstatin ABC kit, Vector 
 
18 
Laboratories) was used as staining procedure. Secondary Ab Goat 
anti-mouse were incubated at room temperature in a humidified 
chamber for 1 hour. Once removed the excess of secondary 
antibodies through PBS washing for 15 minutes, the sections were 
incubated with the ABC complex for 1 hour at room temperature. 
After a further passage in PBS the peroxidase activity was detected 
with 3,3’-diaminobenzidine (DAB) according to the manufacturer’s 
protocol (Vector Laboratories). The sections were than 
counterstained with haematoxylin and cover slipped for microscopic 
analysis.  
 
 
Data collection 
 
Photomicrographs were obtained from immuno-stained serial 
sections at x100 and x200 magnification resembling nonoverlapping 
tessels of the full section. Immunopositive cells where identified after 
adjustment of white balance and normalisation for possible 
background activity in areas not occupied by ganglion cells and the 
negative controls, in which the primary antibody was replaced by 
dilution medium only. Counting of positive and negative cells as well 
as large and small cell subsets was carried out by ImageJ® software 
after implementation of the cell counter plug-in. All data where 
immediately transferred into Microsoft Exel® and later into PAST® 
for further statistic analysis (see below). The investigator was fully 
blinded for the origin of the tissues. In order to achieve are 
standardised data collection, in a pilot procedure the cell counts 
were repeated randomly until the intraobserver variability was less 
than 5%. 
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Statistic Analysis  
 
The distribution characteristics of all parameters was checked by 
Shapiro-Wilk test and normal probability plotting. Regarding the 
former a p-value ≤ 0.05 was considered indicating loss of normality. 
Grouping of data into the semi-quantitative scores (0-3) was 
evaluated via Chi-Square test with a significance threshold of p ≤ 
0.05. Normal data where compared by Students T-Test. A p-value ≤ 
0.05 was accepted as indicating a significant difference between the 
groups. 
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Results 
 
 
Technical Considerations 
 
The immunohistochemical protocol realized for this investigation has 
given successful results in terms of detection of the Voltage Gated 
Calcium Channel alpha 2 delta subunit in all sections tested of the 
Dorsal Root Ganglia of dog. The method described has furthermore 
proven to be reproducible giving a uniform pattern of 
immunoreactivity in terms of both distribution and intensity of 
staining that we have reached. Background staining associated to 
DAB detection technique, which can represent an issue in 
immunohistochemical prepared sections, was minimal and specific 
precipitates of the chromagen were easily identified without 
significant influence over the outcome of the microscopic analysis. 
 
 
 
Fig. 4. Histological section of Dorsal Root Ganglia showing neurons with various 
degrees of immunopositivity toward VGCC alpha 2 delta subunit (brown cells) 
and immunonegative neurons (blue cells). 
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Obtained Values 
 
Dorsal root ganglia were harvested from a total of 24 dogs. The two 
groups were constituted of 16 animals for the neonates group and 8 
animals for the adults group. 
The quantitative analysis in the neonates group showed a total of 
56.907 cells with an immunopositivity for the VGCC alpha 2 subunit 
expressed in 22.521 cells (40%). The morphometric evaluation of 
the cells has been performed on a total of 4.458 stained cells, with 
2.849 small sized cells (64%) and 1.609 large sized cells (36%). 
In the adults group a total of 19.448 cells were counted with 10.962 
(56%) cells exhibiting VGCC alpha 2 subunit immunopositivity within 
the cytoplasm. A total of 3.516 immunoreactive cells with a visible 
nucleus and nucleolus were examined for cell sizes, subsequently 
divided into 2.041 small sized cells (58%) and 1.475 large sized 
cells (42%). 
 
 
Fig 5. Comparison of the mean percentage of positive stained cells in the 
different segment among neonates and adults. 
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In the following description we are going to have a detailed look at 
the differences between the two groups, considering each single 
segment of the Dorsal Root Ganglia evaluated. In the text the values 
expressed in parenthesis represent the standard deviation. 
 
 
Immunohistochemical analysis 
 
The cervical segment C4 of neonates group displayed a mean of 
143 stained cells (± 88.5) while in the adult group the same value 
accounted for 184 (± 66). The mean percentage of stained cells in 
this segment was 32.1% (± 16,7) in the neonates group and 62% 
(±15,8) for the adults. C4 mean total value of grade 1 positive cells 
accounted for 95.6 (± 68.3) with a mean percentage value of 20,9% 
(± 11.9) in the neonates group and 86,2 (± 29.3) with a mean 
percentage value of 29.2% (± 7.3) in the adults group. The mean 
total value of grade 2 stained cells was of 33.7 (± 20.4) 
corresponding to a mean percentage value of 7.8% (± 4.7) in the 
neonates while in the adults the mean total value was 69.6 (± 29) 
and a mean percentage value of 23.4% (± 7.5). Grade 3 positive 
cells had a mean total value of 13.6 (± 10.7) with a mean 
percentage value of 3.4% (± 3.1) in the newborns and values of 28.1 
(± 17) and of 9.4% (± 4.9) in the adults. 
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Fig. 6. Percentage distribution of the immunopositivity to VGCC alpha2 delta 
subunit in the cervical segment C4 in the neonates group. 
 
 
 
Fig. 7. Percentage distribution of the immunopositivity to VGCC alpha2 subunit 
in the cervical segment C4 in the adults group. 
 
 
Examining the C7 segment we found a mean total number of 
positive cells of 262.5 (± 71.8) corresponding to a mean percentage 
value of 42.1% (± 6.4) in the neonates group. In the adults group 
these values accounted for a mean total value of 262.3 (± 74.6) and 
a mean percentage value of 61.8% (± 16.2). The mean total value of 
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grade 1 stained cells in this segment was of 175.5 (± 56.1) in the 
newborns with a mean percentage value of 28% (± 6) while in the 
adults the results were 139.3 (± 42.4) and 32.6% (± 8.8), 
respectively. Grade 2 positive cells in the C7 segment accounted for 
a mean total value of 57.5 (± 19) with a mean percentage value of 
9.2% (± 2.2) in the neonates group and a mean total value of 84.4 (± 
37.7) and a mean percentage of 20% (± 8.7) in the adults. The 
mean total value of grade 3 stained cells was 29.5 (± 13.4) 
corresponding to a mean percentage value of 4.9% (± 2.2) in the 
neonates while in the adults they were respectively 38.6 (± 19.7) 
and 9.2% (± 4.7). 
The lumbar segment L4 showed a mean total value of positive cells 
of 173.5 (± 43.8) in the neonates and a mean percentage of 39.3% 
(± 6.4). In the adults these values were 120.9 (± 41.5) for the mean 
total value and 45.9% (± 12.2) as mean percentage. L4 mean total 
value of grade 1 stained cells accounted for 120.4 (± 34.4) with a 
mean percentage of 26.9% (± 4.2) in the neonates group and 61.6 
(± 22.1) with a percentage value of 23% (± 5.3) in the remaining 
group. Grade2 stained cells had a mean total value of 35.8 (± 12.4) 
in the neonates, with a corresponding mean percentage of 8,2% (± 
2.5). In the adults these values were respectively 36.9 (± 14.4) for 
the mean total value and 14.3% (standard deviation ± 5.4) for the 
mean percentage. In the neonates group the mean total number of 
grade 3 positive cells was of 17.3 (± 6.9) with a mean percentage 
value of 4.2% (± 2.4), while in the other group the mean total 
number accounted for 22.4 (± 14.3) corresponding to a mean 
percentage of 8.5% (± 4.7). 
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Fig. 8. Percentage distribution of the immunopositivity to VGCC alpha2 delta 
subunit in the lumbar segment L7 in the neonates group. 
 
 
 
Fig. 9. Percentage distribution of the immunopositivity to VGCC alpha2 delta 
subunit in the lumbar segment L7 in the adults group. 
 
Considering the latest lumbar segment L7 we found a mean total 
number of positive cells of 185.1 (± 83.5) with a mean percentage of 
43.6% (± 7.7) in the neonates group. In the adults group the mean 
total number of positive cells was 161.1 (± 51.2) corresponding to a 
mean percentage value of 56.6% (±13.4). Grade 1 stained cells in 
the lumbar segment L7 had a mean value of 124.8 (± 63) in the 
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neonates group with a mean percentage of 27.9% (± 8,4) while in 
the adults group they were respectively of 76.4 (± 24) and 26.8% (± 
6.1). The mean total value of grade 2 stained cells was 38.4 (± 20.8) 
with a mean percentage of 9% (± 3.3) in the neonates group while in 
the remaining group it accounted for a mean total number of 50.8 (± 
18.3) and a mean percentage value of 18.3% (± 7.2). Grade 3 
positive cells mean total number was 21.8 (± 11.4) in the newborns 
with a mean percentage value of 6.7% (± 5). In the adults group the 
mean total number of grade 3 stained cells was 34 (± 16) 
corresponding to a mean percentage value of 11.6 (± 4.1). 
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Morphometric evaluation of the immunopositive cells 
 
The results pertaining the evaluation of cells sizes are summarized 
in the table Xy and represented in the figures a and b. 
 
Table 1: Mean total value of large and small sized cells in the four 
segments examined in the entire population. N= neonates, A=adults. 
 
C4 
 
C7 
 
L4 
 
L7 
 Cell Size  
 N A N A N A N A 
Mean 18,5 32,4 30,9 35,3 24,7 36,9 22,6 30,9 Small Cells 
 
 SD 13,1 17,4 12 14,8 9 16,5 14,4 16,9 
Mean 14 17,9 24,3 31,4 9,1 23,6 6,4 24,6 Large Cells 
 
 SD 9,3 5,5 9,9 13,5 4,7 11,1 5,5 12,3 
 
 
 
 
Fig. 10. Comparison of the mean total value of small sized cells in the different 
segment among neonates and adults. 
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Fig. 11. Comparison of the mean total value of large sized cells in the different 
segment among neonates and adults. 
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Statistical Analysis 
 
 
Cervical Segment C4 
 
The total expression in percentage and the levels of expression of 
the VGCC alpha2 subunit according to the test for normality showed 
for both groups a normal distribution (both p > 0.95) in the cervical 
segment C4.  
If compared to puppies, the adult dogs showed significantly (p< 
0.001) increased numbers of neurons expressing the antigen. 
Moreover, the level of expression in the adult animals was in general 
higher and medium (2) and upper score (3) values were met by a 
significantly larger number of neurons (p ≤ 0.05). 
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Fig. 12. Box plot showing the percentages of immunopositive cells C4 segment. 
A = neonates, B = adults. 
 
Considering the ratio between Large and Small sized 
immunopositive neurons remarkably, the distribution of 
immunopositivity amongst the DRG cell populations does not vary 
significantly between adults and puppies (p> 0.8). 
 
 
 
 
Fig. 13. Large:small sized immunopositive cell ratio in neonates at C4 level. 
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Fig. 14. Large:small sized immunopositive cell ratio in Adults at C4 level. 
 
 
Cervical segment C7 
 
For both groups the total expression percentage and the expression 
levels values show approximately a normal distribution (puppies p > 
0.98 / adults p > 0.93). 
If compared to puppies, the adult dogs showed significantly (p< 
0.001) increased numbers of neurons expressing the antigen. 
Compared to C4 a smaller percentage of neurons in adult dogs 
reached expression score 3. Still the overall pattern differed 
significantly between puppies and adults (p = 0.014). 
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Fig. 15. Box plot showing the percentages of immunopositive cells at the level of 
C7. A = neonates, B = adults. 
 
 
Considering cells sizes the distribution of immunopositivity amongst 
the DRG cell populations does not vary significantly between adults 
and puppies ( both p> 0.8). 
 
 
Lumbar segment L4 
 
The total expression percentage and the expression levels of 
immunopositive neurons show for both groups values approximately 
of a normal distribution (both p > 0.96). 
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Fig. 16. Normal probability plot – Neonates L4 level. 
 
 
Fig. 17. Normal probability plot – Adults L4 level. 
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Compared to the cervical segments, the difference between puppies 
and adults regarding their percentage of immunopositive cells is 
less, albeit still significant (p = 0.04). Even though the general 
tendency of adult dogs to exhibit strong expression levels is 
preserved, nearly equal percentages of immunonegative and grade 
1 cells render the p-value subsignificant (p = 0.1 for all cells / p = 
0.06 for immunopositive population). However, there still remains a 
larger proportion of score 2 and score 3 expressing cells within 
these lumbar DRGs. 
 
 
Fig. 18. Box plot showing the percentages of immunopositive cells. 
 
 
The distribution of immunopositivity amongst the DRG cell 
populations is normal throughout (puppies p = 0.89 / adults p = 
0.92).  On the other hand, the ratios differ significantly (P = 0.007) 
since the proportion of immunopositive large neurons is remarkably 
higher in adults. 
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Fig. 19. Large:small sized cells ratio in Neonates at L4 level. 
 
 
Fig. 20. Large:small sized cells ratio in Adults at L4 level. 
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Lumbar Segment L7 
 
The test for normality of the total expression percentage and the 
expression levels show for both groups values of approximately a 
normal distribution (puppies p = 0.97 / adults p = 0.94). 
 
 
 
Fig. 21. Box plot showing the percentages of immunopositive cells at L7 level. K= 
neonates L= adults. 
 
 
Despite a considerable overlap of values, the adult animals still 
show a significantly higher number of immunopositive neurons ( p < 
0.001). The overlap again mainly results from a similar percentage 
of immunonegative and score 1 neurons while a significantly higher 
number of neurons in adult DRGs express scores 2 and 3. 
Considering the sizes of the immunopositive cell population statistic 
evaluation of L7 DRG neurons in neonates shows a high degree 
homogeneity even though normality testing still simulates a normal 
distribution (p = 0.29). 
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Fig. 22. Large:small sized cells ratio in neonates at L7. 
 
 
Fig. 23. Large:small sized cells ratio in neonates at L7. 
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The normal distribution is much more convincingly displayed in the 
adult animals (p = 0.9). Notably, discrimination analysis did not 
reveal significant changes in between the different age groups 
regarding the relative involvement of large versus small DRG 
neurons. 
 
 
Comparison of expression parameters in between the different 
spinal segments 
 
Within the dogs there is a tendency of lumbar DRGs to exhibit a 
lower percentage of immunopositive neurons (see Box plot). If 
lumbar and cervical data are pooled, this tendency becomes 
statistically significant (p = 0.005). 
 
 
Fig. 24. Comparison of the immunopositive neurons amongst neonates in the 
different segment. B = C4, C = C7, D = L4, E = L7. 
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Fig. 25. Comparison of the immunopositive neurons amongst Adults in the 
different segment. B= C4, C= C7, D= L4, E= L7. 
 
 
When comparing the expression levels, there is no significant 
change in between the DRGs of the puppies or adults (p = 1.0). 
 
 
 
Fig. 26. Bar diagrams showing the scored cell populations in the different 
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segments amongst puppies. 
 
 
 
Fig. 27. Bar diagrams showing the scored cell populations in the different 
segments amongst adults. 
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Discussion 
 
The present study revealed that all tested dorsal root ganglia of non-
neurologic dogs are immunopositive for the Voltage Gated Calcium 
Channel (VGCC) alpha 2 delta subunit, which appears to be 
relevant for sensory signal transmission similar to other reported 
species including humans (Zeilhofer, 2005). With expression rates of 
about 40% in the neonates and 56% in the adults subjects,the dog 
ranges close to DRGs of rats, in which gene transcription had been 
demonstrated by in situ hybridization study for mRNA of VGCC 
alpha 2 delta 1 and VGCC alpha 2 delta 2 . Canine values, on the 
other hand are slightly different from the situation reported in the 
chicken, where at least 65% of all DRG neurons stained 
immunopositive for VGCC alpha 2 subunit . The discrepancy 
between mammals and volatile species maybe due to the different 
modalities of sensory transmission related to locomotion, with two 
footed and flying animals in one side versus four footed animals on 
the other. 
This is the first systematic investigation of this particular subunit of 
the VGCC in the dog species using immunohistochemistry. In fact, 
looking at the literature the only published studies pertaining VGCC 
in dogs focus their attention on other subunits of this molecule 
and/or in other tissues than the nervous system, and employed 
other techniques than immunohistochemistry such as Western 
blotting and in situ hybridization . From a technical point of view, 
demonstration of VGCC alpha2 delta subunit by 
immunohistochemistry using monoclonal mouse antibodies is fast, 
reproducible and sensible enough to clearly distinguish three 
different degrees of immunopositivity among large and small DRG 
neurons. These facts allows for simple application of 
semiquantitative scoring with intra- and interrater variability of less 
than 5% for repeated measurements. 
Hence, the presented approach had been considered feasible for 
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establishment of base data on the expression of this presynaptic 
channel subunit and implies possible insights in the molecular 
mechanisms of neuropathic pain in the canine species. 
The study consequently draws close to previeous research in other 
mammalian species, like rat, and non-mammalian species, like 
chicken, where researches have been carried on since long on the 
DRG and Calcium channel in relation with neuropathic pain .   
Establishment of normal values, however also has to take the 
neuronal subtypes into consideration, that are mirrored by the 
size/volume of neuronal perikarya. Neuronal cell body size 
increases in the DRG cells during physiological growth and ageing, 
as it does in the brain and spinal motorneurons of mammals and 
amphibians . Throughout the different ages, the functional 
diversification is closely related to either large or small neurons. 
DRG small neurons develop peripheral C fibres and Aδ fibres which 
are responsible for the transmission of thermoception and 
nociceptive information, while large neurons develop peripheral Aα 
and Aβ fibres responsible for the so-called large fibre senses such 
as proprioception, pressure/vibration and tactile processing . Even 
though the absolute cell size in puppies is much lower than in 
adolescent and adult individuals, a certain cut-off between the two 
main populations can be easily identified within single samples. 
Therefore it has been decided to relay the immunohistochemical 
data to these two categories rather than to establish morphometric 
profiles of the individual cells. Thereby, general rules for simple 
stereologic assessments of the DRG have been followed such as 
choosing nonoverlapping serial sections and establishing the cell 
size category only in full perikaryon sections displaying nucleus plus 
nucleolus . 
The purpose of this investigation was to establish base values for 
the expression of VGCC alpha 2 delta subunit under physiologic 
conditions in the DRG of dogs. Consequently neurologically affected 
animals or those with a history consistent with  lameness or spinal 
disease had been excluded. Furthermore all the animals included in 
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the study underwent a full post mortem examination consisting of 
gross inspection and histologic evaluation of all organs and tissues 
including brain, spinal cord, peripheral nerves and muscles. During 
the selection of suitable DRGs on HE stained slides as well as after 
immuno-labelling and counterstaining, the investigator was looking 
out for all histomorphological changes indicating a non-physiologic 
situation. 
Regarding the histological evaluation of the different sections within 
one group of animals, interestingly there were no significant 
differences. From the functional point of view C7, L4 and L7 convey 
sensory information from the limbs to the cervical (C7) or 
lumbosacral intumescence (L4 and L7),while C4 collects 
somatosensory and visceral afferents from the neck rather than the 
limbs. Thus one would rather expect differences in the expression 
pattern between C4 and the intumescences, even that of the lower 
cervical cord. 
Comparing the two group from the histological point of view it is 
easy to recognize the difference in cell size, for the adults have in 
general larger perikarya throughout all neuronal subgroups than 
neonates. This finding is similar to that reported by Martinelli et al. 
on rabbit Dorsal Root Ganglia where the mean volume of the nerve 
cell bodies increased progressively with the advancing of the age . 
Investigations have revealed that the body cell volume of primary 
sensory neurons correlates with the size of the peripheral field of 
innervation, thus it correlates with the body size and surface of the 
animal which change considerably from birth to adulthood (Martinelli 
et al., 2006). Hence, the neuronal density per high power field 
differed also between the two groups. 
Inspite of close expression rates, the immunoreactivity of VGCC 
alpha 2 delta subunit was significantly stronger in the adults. It may 
be that the given pathways were not yet all steadily employed in the 
neonates, in which synapsing in the dorsal horn remains plastic for a 
considerable post partal period (Fitzgerald, 2005). Moreover, ion 
channel regulation is strongly influenced by trophic factors such as 
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nerve growth factor (NGF), glial derived neurotrophic factor (GDNF) 
and epidermal growth factor (EGF), which underly developmental 
changes until the animals are fully developed (Woodal et al., 2008). 
This difference in expression mirrors the extensive induction, 
structural and functional integration and plastic reorganisation of 
sensory processing during the neonatal period, which are 
characterised by longitudinal variations regarding expression of key 
molecules, receptors and channels, including those associated with 
nociception. For these reasons both nociceptive processing and 
experience of pain in newborns and therefore also the detection, 
monitoring and management has to be seen in a completely 
separate setting . 
During the embryologic development nociceptive neurons are 
specified early, even before neuronal crest cells become destined to 
become neuron or glial cells. In the DRG, sensory neurons are 
generated in two waves: large diameter neurons appear first, 
followed by the smaller population . In the rat, the innervation of 
peripheral and central target occurs before birth and reflects this two 
distinct waves of neurogenesis. The A fibres penetrate the dorsal 
horn grey matter of the spinal cord creating synapses at first, during 
embryonic day 15-17 which are then followed by C fibres at day 18-
20 . Furthermore C fibres complete their connections with the 
laminae I and II of the spinal cord around post natal day 5, thus this 
relatively late formation of central C fibre synapses means that, 
despite the ability to detect noxious stimuli at the periphery, the 
central processing is still immature in the early post natal period in 
the rat . The A fibres in the early stages reach predominantly 
laminae I and II, with a subsequent withdrawal toward laminae III 
and IV over the first 3 postnatal weeks . Apart from the physiologic 
modification that occurs during growth, the nervous tissue is capable 
of further adaptation thanks to neuroplasticity. In particular diseases 
affecting the sensory pathways, molecules, receptors, channels and 
even synapses can undergoes significant changes . For example, if 
a neuropathic pain has been induced, these changes impact 
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primarily on C and A δ fibres, small fibres which are responsible of 
pain transmission. In addition, large fibres such as A β fibres, which 
normally transmit proprioceptive information, may experience a 
variation in their phenotype with increased production of 
neurotransmitters implied in pain transmission, such as substance P 
(Jones et al., 2007). These changes come into action by 
reorientation of their synapses in the dorsal horn from laminae III 
and IV to laminae I and II those responsible for the transmission of 
nociceptive informations. . According to our results there was not a 
statistically significant difference between small and large cells, both 
in neonates and adults. Hence we can assume that calcium currents 
are used in the entire sensory transmission and are not restricted to 
a specific function segregating with one single cell type. This finding 
is different from those previously reported in rats and chickens 
where the distribution of the VGCC alpha 2 delta subunit was 
predominantly related to small and medium size neurons (Newton et 
al., 2001, Li et al., 2007). Further interpretation of this difference 
requires comparison of the cut-off criteria. Our tissues did not exhibit 
a trimodal neuron size histogram. The large cell population therefore 
may contain cells that in the other named species present as a third 
ganglion cell subgroup. Morphometry is unlikely to shed further light 
onto this subject. Multilabelling for neurotransmitters and functional 
phenotyping, on the other hand, could help subcategorising the 
groups. 
Within the dogs there is a tendency of lumbar DRGs to exhibit a 
lower percentage of immunopositive neurons, and this is particularly 
evident in the adults where C4 segment has 62% of positive stained 
cells while L4 accounts only for a 44%. A possible explanation for 
this craniocaudal decrement of expression along spinal ganglia may 
be related to functional differences between front limbs and hind 
limbs. Even in the quadrupede dog the front limbs are not used 
merely for walking, but they can do further specialized movements 
which in turn require the transmission of a major sensory amount of 
information. Whether this really is the cause, remains to be tested 
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further.  
Another possible explanation could rely on the fact that at the 
different segment there could be a preference in signalling 
transmission, and maybe in the lumbar segment other molecules 
such as glutamate or Substance P can be prevalent. In order to 
increase the accuracy of the detection and to better understand the 
functional relationships with calcium channel and other molecules on 
the dynamics of sensory transmission, multilabelling studies such as 
those made by Li et al. in .2007 can be of great interest . 
The synaptic transmission of noxious and non-noxious signals in 
neuropathic condition partially depends on presynaptic calcium 
channels that contain VGCC alpha 2 delta subunit. Therefore it has 
been proven that rats show a marked increase in the expression of 
this molecule when a state of neuropathic pain has been established 
in experimental conditions (Newton et al., 2001, Luo et al., 2002).  
Dogs can experience neuropathic pain because several conditions 
such as trauma, surgical procedures, pelvic fractures, limb nerve 
entrapment, amputation, lumbosacral lesions, spinal cord injury, 
intervertebral disc herniation, fibrocartilaginous embolic myelopathy, 
syringomyelia, discospondylitis, polyradiculoneuritis, tumors of the 
central nervous system, inflammatory bowel disease and 
pancreatitis can determine this pathologic condition of the sensory 
pathway (Mathews, 2008, Grubb, 2010). 
To confirm whether a neuropathic pain condition goes along with 
increased expression of the VGCC alpha 2 delta subunit in dogs as 
it has been observed in rats requires further investigation on animals 
with well characterised nerve lesions. Furthermore from the clinical 
point of view, the presence of a different pattern of expression in the 
front limb and hind limb for the VGCC alpha 2 delta subunit that we 
found, can make us wonder whether a dog can have a different 
response to the administration of certain class of drugs like 
gabapentinoids in relation to the site of nerve damage. 
Investigations and clinical trials on this direction in the future will 
help us to better understand and control neuropathic pain. 
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Giving the high number of pathological states that can produce 
neuropathic pain, the clinician must be able to recognize his 
symptoms in a patient that can not express himself verbally and 
treat this debilitating condition appropriately. As previously 
mentioned in this work, in human medicine neuropathic pain 
treatment is a challenge from the clinical point of view because 
despite the efforts made in developing rationale therapeutic 
approach, the response to most treatment is unpredictable with 
moderate or minimal relief using standard analgesic drugs . In the 
recent literature VGCC alpha 2 delta subunit has revealed to be a 
binding site for Gabapentin (GBP) and Pregabalin (PGB) . The 
mechanism of action is still not completely understood but it has 
been reported that these drugs are able to reduce Calcium current in 
the DRG and in the dorsal horn of the spinal cord, thus inhibiting the 
release of excitatory neurotransmitters from presynaptic terminals of 
the DRG neurons . In the studies conducted by Luo et al. 2001 and 
2002 has been observed an increase in the expression of VGCC 
alpha 2 delta subunit in the DRG and spinal dorsal horn of animals 
presenting neuropathic pain that were sensitive to gabapentin thus 
providing evidence for the antineuropathic pain effect of this drug.  
The European Federation of Neurological Societies published in 
2009 the guidelines for neuropathic pain management in humans 
and Gabapentin (GBP) and Pregabalin (PGB) have been elected as 
first drugs of choice for the treatment of this condition . In veterinary 
medicine the treatment of neuropathic pain is as challenging as it is 
for people, with few published data in the literature on the topic. As it 
happens for many drugs, veterinary surgeons has the tendency to 
utilize on the patients drugs that are designed for human treatments 
and are thus used off label for companion animals. This means a 
complete disregard of the principles of Evidence Based Medicine, 
which aims to apply the best available evidence gained from the 
scientific method to clinical decision making. Gabapentinoids are 
currently used in veterinary practice with success for the treatment 
of neuropathic pain, but there are no clinical trial published, and the 
 
48 
data to their efficacy in the dog account for few reports in a small 
dog population . Considering the clinical importance and the 
economical consequences implied by the introduction of a new drug 
for a disease treatment, a more rationale approach should be 
recommended. Therefore our investigation, demonstrating the 
presence of the binding site of gabapentinoids, represents a 
fundamental step toward an Evidence Based Medicine approach in 
the treatment of neuropathic pain in the dog. 
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